GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
14-3-3 protein binding,GO:0071889,Osteoarthritis,MESH:D010003,0,,1,YWHAQ
"17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity",GO:0047006,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
17-beta-hydroxysteroid dehydrogenase (NADP+) activity,GO:0072582,Osteoarthritis,MESH:D010003,0,,1,AKR1C2
2-oxoglutarate-dependent dioxygenase activity,GO:0016706,"Osteoarthritis, Spine",MESH:D055013,0,,1,SKP2
"3',5'-cyclic-AMP phosphodiesterase activity",GO:0004115,Osteoarthritis,MESH:D010003,1,Curcumin,0,
3beta-hydroxy-5beta-steroid dehydrogenase activity,GO:0033703,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,Osteoarthritis,MESH:D010003,2,Curcumin|Indomethacin,0,
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
3-chloroallyl aldehyde dehydrogenase activity,GO:0004028,Osteoarthritis,MESH:D010003,0,,1,ALDH1A2
3-hydroxyacyl-CoA dehydratase activity,GO:0018812,Osteoarthritis,MESH:D010003,0,,1,HADHA
3-hydroxyacyl-CoA dehydrogenase activity,GO:0003857,Osteoarthritis,MESH:D010003,0,,1,HADHA
3-hydroxyisobutyryl-CoA hydrolase activity,GO:0003860,Osteoarthritis,MESH:D010003,0,,1,HIBCH
"3 iron, 4 sulfur cluster binding",GO:0051538,Osteoarthritis,MESH:D010003,0,,1,ACO1
"4 iron, 4 sulfur cluster binding",GO:0051539,Osteoarthritis,MESH:D010003,0,,3,ACO1|NDUFS8|NDUFV1
"5alpha-androstane-3beta,17beta-diol dehydrogenase activity",GO:0047024,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
5'-nucleotidase activity,GO:0008253,Osteoarthritis,MESH:D010003,1,nimesulide,0,
5'-nucleotidase activity,GO:0008253,"Osteoarthritis, Hip",MESH:D015207,1,nimesulide,0,
5'-nucleotidase activity,GO:0008253,"Osteoarthritis, Knee",MESH:D020370,1,nimesulide,0,
5S rRNA binding,GO:0008097,Osteoarthritis,MESH:D010003,0,,1,EEF2
ABC-type transporter activity,GO:0140359,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
acetylcholine-gated monoatomic cation-selective channel activity,GO:0022848,Osteoarthritis,MESH:D010003,1,Nicotine,0,
acetylcholinesterase activity,GO:0003990,Osteoarthritis,MESH:D010003,1,polygalacic acid,0,
acetyl-CoA C-acetyltransferase activity,GO:0003985,Osteoarthritis,MESH:D010003,0,,2,ACAA2|HADHA
acetyl-CoA C-acyltransferase activity,GO:0003988,Osteoarthritis,MESH:D010003,0,,2,ACAA2|HADHA
acetyl-CoA carboxylase activity,GO:0003989,Osteoarthritis,MESH:D010003,2,Dietary Fats|Resveratrol,0,
acetyl-CoA carboxylase activity,GO:0003989,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
[acetyl-CoA carboxylase] kinase activity,GO:0050405,Osteoarthritis,MESH:D010003,2,Ethanol|Lipopolysaccharides,0,
[acetyl-CoA carboxylase] kinase activity,GO:0050405,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
acetyl-CoA hydrolase activity,GO:0003986,Osteoarthritis,MESH:D010003,0,,1,ACAA2
acid phosphatase activity,GO:0003993,Osteoarthritis,MESH:D010003,3,Curcumin|Iron|Resveratrol,0,
acid phosphatase activity,GO:0003993,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
aconitate hydratase activity,GO:0003994,Osteoarthritis,MESH:D010003,1,Dietary Fats,1,ACO1
actin binding,GO:0003779,Osteoarthritis,MESH:D010003,0,,7,EZR|LTBP3|MSN|MYH13|PLS3|S100A4|TRPV4
actin binding,GO:0003779,"Osteoarthritis, Hip",MESH:D015207,0,,2,LTBP3|MAPT
actin filament binding,GO:0051015,Osteoarthritis,MESH:D010003,0,,5,EEF2|EZR|MYH13|PLS3|TRPV4
active monoatomic ion transmembrane transporter activity,GO:0022853,Osteoarthritis,MESH:D010003,1,Nicotine,0,
acyl-CoA hydrolase activity,GO:0047617,Osteoarthritis,MESH:D010003,0,,1,ACAA2
acyltransferase activity,GO:0016746,Osteoarthritis,MESH:D010003,0,,2,ACAA2|TGM2
"acyltransferase activity, transferring groups other than amino-acyl groups",GO:0016747,Osteoarthritis,MESH:D010003,0,,1,ACAA2
adenylate kinase activity,GO:0004017,Osteoarthritis,MESH:D010003,0,,1,AK4
ADP phosphatase activity,GO:0043262,Osteoarthritis,MESH:D010003,1,Caffeine,0,
adrenergic receptor activity,GO:0004935,Osteoarthritis,MESH:D010003,1,Nicotine,0,
advanced glycation end-product receptor activity,GO:0050785,Osteoarthritis,MESH:D010003,0,,2,AGER|LGALS3
alcohol dehydrogenase (NAD+) activity,GO:0004022,Osteoarthritis,MESH:D010003,1,Curcumin,0,
aldehyde dehydrogenase (NAD+) activity,GO:0004029,Osteoarthritis,MESH:D010003,0,,2,ALDH1A2|NDUFS8
aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,Osteoarthritis,MESH:D010003,1,Ethanol,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,Osteoarthritis,MESH:D010003,1,Capsaicin,2,AKR1C1|AKR1C2
aldo-keto reductase (NADP) activity,GO:0004033,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
alkaline phosphatase activity,GO:0004035,Osteoarthritis,MESH:D010003,9,Acetaminophen|Curcumin|Diclofenac|Dietary Fats|Ethanol|fisetin|Lipopolysaccharides|Nicotine|Resveratrol,0,
alkaline phosphatase activity,GO:0004035,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
alpha-actinin binding,GO:0051393,Osteoarthritis,MESH:D010003,0,,1,PPARG
alpha-amylase activity,GO:0004556,Osteoarthritis,MESH:D010003,2,Curcumin|Resveratrol,0,
alpha-amylase activity,GO:0004556,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
alpha-tubulin binding,GO:0043014,Osteoarthritis,MESH:D010003,0,,1,TRPV4
AMP-activated protein kinase activity,GO:0004679,Osteoarthritis,MESH:D010003,7,Caffeine|Dietary Fats|Ethanol|Lipopolysaccharides|Nicotine|Resveratrol|xanthohumol,0,
AMP-activated protein kinase activity,GO:0004679,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
amylase activity,GO:0016160,Osteoarthritis,MESH:D010003,2,Ethanol|Lipopolysaccharides,0,
amylase activity,GO:0016160,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
amyloid-beta binding,GO:0001540,Osteoarthritis,MESH:D010003,0,,3,AGER|ATP1A3|CLU
"androstan-3-alpha,17-beta-diol dehydrogenase activity",GO:0047044,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
androsterone dehydrogenase activity,GO:0047023,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
androsterone dehydrogenase (B-specific) activity,GO:0047042,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
antigen binding,GO:0003823,Osteoarthritis,MESH:D010003,0,,1,TGFB1
antioxidant activity,GO:0016209,Osteoarthritis,MESH:D010003,3,"Curcumin|Dietary Fats|pregna-4,17-diene-3,16-dione",1,SOD2
apolipoprotein binding,GO:0034185,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
arachidonic acid binding,GO:0050544,Osteoarthritis,MESH:D010003,0,,1,PPARG
arginase activity,GO:0004053,Osteoarthritis,MESH:D010003,1,Caffeine,0,
aryl sulfotransferase activity,GO:0004062,Osteoarthritis,MESH:D010003,1,Acetaminophen,0,
aspartic-type endopeptidase activity,GO:0004190,Osteoarthritis,MESH:D010003,0,,3,CLIC1|CTSD|SGCG
aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902944,Osteoarthritis,MESH:D010003,1,Nicotine,0,
aspartic-type endopeptidase inhibitor activity,GO:0019828,Osteoarthritis,MESH:D010003,0,,1,GAPDH
aspartic-type peptidase activity,GO:0070001,Osteoarthritis,MESH:D010003,0,,1,CTSD
ATPase binding,GO:0051117,Osteoarthritis,MESH:D010003,0,,1,EZR
ATP binding,GO:0005524,Osteoarthritis,MESH:D010003,0,,13,ACTB|AK4|ATP1A3|ATP6V1B2|DDX3X|EEF2|MSN|MYH13|NME2|RUNX2|TRAP1|TRPV4|VDAC2
ATP binding,GO:0005524,"Osteoarthritis, Hip",MESH:D015207,0,,1,RUNX2
ATP-dependent activity,GO:0140657,Osteoarthritis,MESH:D010003,2,Caffeine|Iron,0,
ATP-dependent activity,GO:0140657,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
ATP-dependent protein folding chaperone,GO:0140662,Osteoarthritis,MESH:D010003,0,,1,TRAP1
ATP hydrolysis activity,GO:0016887,Osteoarthritis,MESH:D010003,4,Acetaminophen|Dietary Fats|Lipopolysaccharides|Resveratrol,4,ACTB|ATP1A3|DDX3X|TRAP1
ATP hydrolysis activity,GO:0016887,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
beta-2-microglobulin binding,GO:0030881,"Osteoarthritis, Hip",MESH:D015207,0,,1,HFE
beta-catenin binding,GO:0008013,Osteoarthritis,MESH:D010003,0,,1,SMAD3
beta-catenin binding,GO:0008013,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
beta-galactosidase activity,GO:0004565,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
beta-galactosidase activity,GO:0004565,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
beta-lactamase activity,GO:0008800,Osteoarthritis,MESH:D010003,0,,1,DPEP1
beta-tubulin binding,GO:0048487,Osteoarthritis,MESH:D010003,0,,1,TRPV4
bHLH transcription factor binding,GO:0043425,Osteoarthritis,MESH:D010003,0,,2,RUNX2|SMAD3
bHLH transcription factor binding,GO:0043425,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
bile acid binding,GO:0032052,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
BMP binding,GO:0036122,Osteoarthritis,MESH:D010003,0,,2,COMP|GDF5
BMP binding,GO:0036122,"Osteoarthritis, Hip",MESH:D015207,0,,1,COMP
BMP binding,GO:0036122,"Osteoarthritis, Knee",MESH:D020370,0,,1,GDF5
BMP receptor binding,GO:0070700,Osteoarthritis,MESH:D010003,0,,2,BMP4|BMP6
butyrate-CoA ligase activity,GO:0047760,Osteoarthritis,MESH:D010003,1,Diclofenac,0,
calcitonin receptor binding,GO:0031716,Osteoarthritis,MESH:D010003,0,,1,CALCA
calcium channel activity,GO:0005262,Osteoarthritis,MESH:D010003,1,Capsaicin,1,TRPV4
calcium-dependent ATPase activity,GO:0030899,Osteoarthritis,MESH:D010003,2,Aspirin|Dietary Fats,0,
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,Osteoarthritis,MESH:D010003,1,Acetaminophen,0,
calcium-dependent phospholipid binding,GO:0005544,Osteoarthritis,MESH:D010003,0,,1,PLCD1
calcium-dependent protein binding,GO:0048306,Osteoarthritis,MESH:D010003,0,,2,PDCD6IP|S100A4
calcium ion binding,GO:0005509,Osteoarthritis,MESH:D010003,0,,11,ASPN|COMP|EDIL3|LTBP3|MATN3|PLCD1|PLS3|RCN3|S100A4|TGM2|TRAP1
calcium ion binding,GO:0005509,"Osteoarthritis, Hip",MESH:D015207,0,,4,ASTN2|COMP|ITIH1|LTBP3
calcium ion binding,GO:0005509,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
calcium ion binding,GO:0005509,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
calmodulin binding,GO:0005516,Osteoarthritis,MESH:D010003,0,,2,MYH13|TRPV4
calmodulin-dependent protein phosphatase activity,GO:0033192,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
cAMP-dependent protein kinase inhibitor activity,GO:0004862,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
carbohydrate binding,GO:0030246,Osteoarthritis,MESH:D010003,0,,2,CHI3L1|LGALS3
carbohydrate binding,GO:0030246,"Osteoarthritis, Hip",MESH:D015207,0,,1,ITIH1
carbohydrate binding,GO:0030246,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
carbonate dehydratase activity,GO:0004089,Osteoarthritis,MESH:D010003,1,Caffeine,0,
carboxylic acid binding,GO:0031406,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
carboxylic ester hydrolase activity,GO:0052689,Osteoarthritis,MESH:D010003,1,Dietary Fats,1,ESD
cardiolipin binding,GO:1901612,Osteoarthritis,MESH:D010003,0,,1,OPA1
carnitine O-octanoyltransferase activity,GO:0008458,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
carnitine O-palmitoyltransferase activity,GO:0004095,Osteoarthritis,MESH:D010003,2,Dietary Fats|Resveratrol,0,
carnitine O-palmitoyltransferase activity,GO:0004095,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
catalytic activity,GO:0003824,Osteoarthritis,MESH:D010003,0,,1,EDIL3
CD40 receptor binding,GO:0005174,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
cell adhesion molecule binding,GO:0050839,Osteoarthritis,MESH:D010003,0,,3,EZR|MSN|SDCBP
ceramide binding,GO:0097001,Osteoarthritis,MESH:D010003,0,,1,VDAC2
channel activity,GO:0015267,Osteoarthritis,MESH:D010003,1,Capsaicin,1,VDAC2
chaperone binding,GO:0051087,Osteoarthritis,MESH:D010003,0,,2,ATP1A3|CLU
chaperone binding,GO:0051087,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
chemoattractant activity,GO:0042056,Osteoarthritis,MESH:D010003,0,,3,BMP4|LGALS3|S100A4
chemokine activity,GO:0008009,Osteoarthritis,MESH:D010003,0,,2,CXCL2|CXCL6
chemokine activity,GO:0008009,"Osteoarthritis, Spine",MESH:D055013,0,,1,CXCL8
chitin binding,GO:0008061,Osteoarthritis,MESH:D010003,0,,1,CHI3L1
chloride channel activity,GO:0005254,Osteoarthritis,MESH:D010003,0,,2,CLIC1|CLIC4
cholesterol binding,GO:0015485,Osteoarthritis,MESH:D010003,0,,1,VDAC2
cholinesterase activity,GO:0004104,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
chromatin binding,GO:0003682,Osteoarthritis,MESH:D010003,0,,4,PPARG|RAN|RUNX2|SMAD3
chromatin binding,GO:0003682,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
chromatin DNA binding,GO:0031490,Osteoarthritis,MESH:D010003,0,,2,RUNX2|SMAD3
chromatin DNA binding,GO:0031490,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
chromatin DNA binding,GO:0031490,"Osteoarthritis, Knee",MESH:D020370,0,,1,SBNO1
cis-regulatory region sequence-specific DNA binding,GO:0000987,Osteoarthritis,MESH:D010003,0,,2,RUNX2|SMAD3
cis-regulatory region sequence-specific DNA binding,GO:0000987,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
CMP kinase activity,GO:0036430,Osteoarthritis,MESH:D010003,0,,1,AK4
collagen binding,GO:0005518,Osteoarthritis,MESH:D010003,0,,5,COL6A2|COMP|CTSK|P3H3|SMAD3
collagen binding,GO:0005518,"Osteoarthritis, Hip",MESH:D015207,0,,3,CHADL|COMP|SMAD3
collagen binding involved in cell-matrix adhesion,GO:0098639,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
collagen binding involved in cell-matrix adhesion,GO:0098639,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
collagen fibril binding,GO:0098633,"Osteoarthritis, Hip",MESH:D015207,0,,1,CHADL
collagen V binding,GO:0070052,Osteoarthritis,MESH:D010003,0,,1,ASPN
co-receptor binding,GO:0039706,Osteoarthritis,MESH:D010003,0,,1,BMP4
co-receptor binding,GO:0039706,"Osteoarthritis, Hip",MESH:D015207,0,,1,HFE
corticotrophin-releasing factor receptor activity,GO:0015056,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
corticotropin-releasing hormone binding,GO:0051424,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
corticotropin-releasing hormone receptor activity,GO:0043404,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
co-SMAD binding,GO:0070410,Osteoarthritis,MESH:D010003,0,,1,SMAD3
co-SMAD binding,GO:0070410,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
creatine kinase activity,GO:0004111,Osteoarthritis,MESH:D010003,5,Dietary Fats|Doxycycline|Lipopolysaccharides|Resveratrol|Tramadol,0,
creatine kinase activity,GO:0004111,"Osteoarthritis, Knee",MESH:D020370,3,Lipopolysaccharides|Resveratrol|Tramadol,0,
CTPase activity,GO:0043273,Osteoarthritis,MESH:D010003,0,,1,DDX3X
CXCR chemokine receptor binding,GO:0045236,Osteoarthritis,MESH:D010003,0,,2,CXCL2|CXCL6
CXCR chemokine receptor binding,GO:0045236,"Osteoarthritis, Spine",MESH:D055013,0,,1,CXCL8
cysteine-type endopeptidase activity,GO:0004197,Osteoarthritis,MESH:D010003,4,Capsaicin|Celecoxib|Ethanol|Lipopolysaccharides,2,CTSD|CTSK
cysteine-type endopeptidase activity,GO:0004197,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043027,Osteoarthritis,MESH:D010003,0,,1,DPEP1
cysteine-type exopeptidase activity,GO:0070004,Osteoarthritis,MESH:D010003,0,,1,SCRN1
cysteine-type peptidase activity,GO:0008234,Osteoarthritis,MESH:D010003,1,astaxanthine,1,CTSK
cytochrome-c oxidase activity,GO:0004129,Osteoarthritis,MESH:D010003,9,Acetaminophen|Aspirin|Celecoxib|Curcumin|Dietary Fats|Ethanol|Iron|Lipopolysaccharides|Resveratrol,0,
cytochrome-c oxidase activity,GO:0004129,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
cytokine activity,GO:0005125,Osteoarthritis,MESH:D010003,0,,7,BMP4|BMP6|CXCL2|GDF5|IL1B|TGFB1|TNFSF15
cytokine activity,GO:0005125,"Osteoarthritis, Hip",MESH:D015207,0,,1,IL11
cytokine activity,GO:0005125,"Osteoarthritis, Knee",MESH:D020370,0,,1,GDF5
cytokine activity,GO:0005125,"Osteoarthritis, Spine",MESH:D055013,0,,2,IL6|TNF
cytoskeletal anchor activity,GO:0008093,Osteoarthritis,MESH:D010003,0,,1,SDCBP
cytoskeletal motor activity,GO:0003774,Osteoarthritis,MESH:D010003,0,,1,MYH13
D1 dopamine receptor binding,GO:0031748,Osteoarthritis,MESH:D010003,0,,1,ATP1A3
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,Osteoarthritis,MESH:D010003,2,Curcumin|Ethanol,0,
dCMP kinase activity,GO:0036431,Osteoarthritis,MESH:D010003,0,,1,AK4
DEAD/H-box RNA helicase binding,GO:0017151,Osteoarthritis,MESH:D010003,0,,1,SMAD3
DEAD/H-box RNA helicase binding,GO:0017151,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
death receptor agonist activity,GO:0038177,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
death receptor binding,GO:0005123,Osteoarthritis,MESH:D010003,0,,1,TNFSF15
dehydroascorbic acid transmembrane transporter activity,GO:0033300,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
(deoxy)adenylate kinase activity,GO:0047506,Osteoarthritis,MESH:D010003,0,,1,AK4
deubiquitinase activator activity,GO:0035800,Osteoarthritis,MESH:D010003,0,,1,TGFB1
D-glucose transmembrane transporter activity,GO:0055056,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
dioxygenase activity,GO:0051213,Osteoarthritis,MESH:D010003,0,,3,P3H3|PLOD2|PTGS2
dipeptidase activity,GO:0016805,Osteoarthritis,MESH:D010003,0,,2,DPEP1|SCRN1
disaccharide binding,GO:0048030,Osteoarthritis,MESH:D010003,0,,1,LGALS3
disordered domain specific binding,GO:0097718,Osteoarthritis,MESH:D010003,0,,2,EZR|GAPDH
DNA binding,GO:0003677,Osteoarthritis,MESH:D010003,0,,9,AGER|DDX3X|NME2|POU3F3|PPARG|RUNX2|SGCG|SMAD3|SOD2
DNA binding,GO:0003677,"Osteoarthritis, Hip",MESH:D015207,0,,4,LMX1B|MAPT|RUNX2|SMAD3
DNA binding domain binding,GO:0050692,Osteoarthritis,MESH:D010003,0,,1,PPARG
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,Osteoarthritis,MESH:D010003,0,,3,PPARG|RUNX2|SMAD3
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,"Osteoarthritis, Hip",MESH:D015207,0,,3,LMX1B|RUNX2|SMAD3
DNA-binding transcription factor activity,GO:0003700,Osteoarthritis,MESH:D010003,1,Lipopolysaccharides,4,POU3F3|PPARG|RUNX2|SMAD3
DNA-binding transcription factor activity,GO:0003700,"Osteoarthritis, Hip",MESH:D015207,0,,3,LMX1B|RUNX2|SMAD3
DNA-binding transcription factor activity,GO:0003700,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,Osteoarthritis,MESH:D010003,0,,4,POU3F3|PPARG|RUNX2|SMAD3
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,"Osteoarthritis, Hip",MESH:D015207,0,,3,LMX1B|RUNX2|SMAD3
DNA-binding transcription factor binding,GO:0140297,Osteoarthritis,MESH:D010003,0,,3,PPARG|RUNX2|SMAD3
DNA-binding transcription factor binding,GO:0140297,"Osteoarthritis, Hip",MESH:D015207,0,,3,HDAC9|RUNX2|SMAD3
DNA-binding transcription repressor activity,GO:0001217,Osteoarthritis,MESH:D010003,0,,1,SMAD3
DNA-binding transcription repressor activity,GO:0001217,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,Osteoarthritis,MESH:D010003,0,,2,ENO1|PPARG
DNA helicase activity,GO:0003678,Osteoarthritis,MESH:D010003,0,,1,DDX3X
DNA-methyltransferase activity,GO:0009008,Osteoarthritis,MESH:D010003,3,Curcumin|Decitabine|Dietary Fats,0,
double-stranded DNA binding,GO:0003690,Osteoarthritis,MESH:D010003,0,,3,PPARG|SMAD3|TRIM2
double-stranded DNA binding,GO:0003690,"Osteoarthritis, Hip",MESH:D015207,0,,2,MAPT|SMAD3
double-stranded RNA binding,GO:0003725,Osteoarthritis,MESH:D010003,0,,2,MSN|VIM
dynactin binding,GO:0034452,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
dynein intermediate chain binding,GO:0045505,Osteoarthritis,MESH:D010003,0,,1,RAN
E-box binding,GO:0070888,Osteoarthritis,MESH:D010003,0,,1,PPARG
electron transfer activity,GO:0009055,Osteoarthritis,MESH:D010003,0,,3,ETFA|PSMB1|SDHA
endopeptidase activity,GO:0004175,Osteoarthritis,MESH:D010003,0,,1,CTSD
endopeptidase inhibitor activity,GO:0004866,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
enoyl-CoA hydratase activity,GO:0004300,Osteoarthritis,MESH:D010003,0,,1,HADHA
enzyme binding,GO:0019899,Osteoarthritis,MESH:D010003,0,,11,ENO1|GAPDH|MSN|NME2|PLCD1|PPARG|PTGS2|SMAD3|SOD2|TGFB1|TGM2
enzyme binding,GO:0019899,"Osteoarthritis, Hip",MESH:D015207,0,,2,MAPT|SMAD3
ephrin receptor binding,GO:0046875,Osteoarthritis,MESH:D010003,0,,1,SDCBP
estradiol 17-beta-dehydrogenase activity,GO:0004303,Osteoarthritis,MESH:D010003,2,Curcumin|Indomethacin,2,AKR1C1|AKR1C2
estradiol 17-beta-dehydrogenase activity,GO:0004303,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
eukaryotic initiation factor 4E binding,GO:0008190,Osteoarthritis,MESH:D010003,0,,1,DDX3X
extracellular matrix binding,GO:0050840,"Osteoarthritis, Hip",MESH:D015207,0,,1,COL11A1
extracellular matrix structural constituent,GO:0005201,Osteoarthritis,MESH:D010003,0,,7,CHI3L1|COL1A2|COL2A1|COMP|EDIL3|MATN3|TFPI2
extracellular matrix structural constituent,GO:0005201,"Osteoarthritis, Hip",MESH:D015207,0,,3,COL11A1|COMP|TNC
extracellular matrix structural constituent,GO:0005201,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
extracellular matrix structural constituent,GO:0005201,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
extracellular matrix structural constituent,GO:0005201,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
extracellular matrix structural constituent conferring compression resistance,GO:0030021,Osteoarthritis,MESH:D010003,0,,1,ASPN
extracellular matrix structural constituent conferring compression resistance,GO:0030021,"Osteoarthritis, Hip",MESH:D015207,0,,1,CHADL
extracellular matrix structural constituent conferring compression resistance,GO:0030021,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
extracellular matrix structural constituent conferring tensile strength,GO:0030020,Osteoarthritis,MESH:D010003,0,,3,COL1A2|COL2A1|COL6A2
extracellular matrix structural constituent conferring tensile strength,GO:0030020,"Osteoarthritis, Hip",MESH:D015207,0,,1,COL11A1
extracellular matrix structural constituent conferring tensile strength,GO:0030020,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
FAD binding,GO:0071949,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
fatty acid binding,GO:0005504,Osteoarthritis,MESH:D010003,0,,1,NME2
fatty-acyl-CoA binding,GO:0000062,Osteoarthritis,MESH:D010003,0,,1,HADHA
Fc-gamma receptor I complex binding,GO:0034988,Osteoarthritis,MESH:D010003,0,,1,LGALS3
ferric iron binding,GO:0008199,Osteoarthritis,MESH:D010003,0,,2,ETFA|FTL
ferrous iron binding,GO:0008198,Osteoarthritis,MESH:D010003,0,,1,FTL
ferroxidase activity,GO:0004322,Osteoarthritis,MESH:D010003,1,Ethanol,0,
fibroblast growth factor receptor binding,GO:0005104,Osteoarthritis,MESH:D010003,0,,1,FGF18
fibronectin binding,GO:0001968,Osteoarthritis,MESH:D010003,0,,2,COMP|CTSK
fibronectin binding,GO:0001968,"Osteoarthritis, Hip",MESH:D015207,0,,2,COMP|TNC
flavin adenine dinucleotide binding,GO:0050660,Osteoarthritis,MESH:D010003,0,,3,ETFA|SDHA|TXNRD1
FMN binding,GO:0010181,Osteoarthritis,MESH:D010003,0,,1,NDUFV1
frizzled binding,GO:0005109,Osteoarthritis,MESH:D010003,0,,1,SDCBP
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
fucose transmembrane transporter activity,GO:0015150,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
galactoside binding,GO:0016936,Osteoarthritis,MESH:D010003,0,,1,LGALS3
gamma-tubulin binding,GO:0043015,Osteoarthritis,MESH:D010003,0,,1,DDX3X
ganglioside GM1 binding,GO:1905573,"Osteoarthritis, Hip",MESH:D015207,0,,1,CHADL
ganglioside GT1b binding,GO:1905576,"Osteoarthritis, Hip",MESH:D015207,0,,1,CHADL
gap junction channel activity,GO:0005243,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
gap junction channel activity,GO:0005243,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
gap junction hemi-channel activity,GO:0055077,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
GDP binding,GO:0019003,Osteoarthritis,MESH:D010003,0,,2,NME2|RAN
general transcription initiation factor binding,GO:0140296,Osteoarthritis,MESH:D010003,0,,1,RUNX2
general transcription initiation factor binding,GO:0140296,"Osteoarthritis, Hip",MESH:D015207,0,,1,RUNX2
glucose-6-phosphatase activity,GO:0004346,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
glutamate binding,GO:0016595,Osteoarthritis,MESH:D010003,1,Ethanol,0,
glutaminase activity,GO:0004359,Osteoarthritis,MESH:D010003,0,,1,GLS
glutathione-disulfide reductase (NADPH) activity,GO:0004362,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
glutathione peroxidase activity,GO:0004602,Osteoarthritis,MESH:D010003,17,Acetaminophen|Aspartame|Caffeine|Curcumin|Diclofenac|Dietary Fats|Ethanol|ferrostatin-1|fisetin|Indomethacin|Iron|Lipopolysaccharides|Lithium Chloride|Meloxicam|morroniside|Nicotine|Resveratrol,1,GSTK1
glutathione peroxidase activity,GO:0004602,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
glutathione peroxidase activity,GO:0004602,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
glutathione transferase activity,GO:0004364,Osteoarthritis,MESH:D010003,9,Acetaminophen|Caffeine|Curcumin|Dietary Fats|Ethanol|Iron|Lipopolysaccharides|Nicotine|Resveratrol,1,GSTK1
glutathione transferase activity,GO:0004364,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,Osteoarthritis,MESH:D010003,1,Iodoacetic Acid,1,GAPDH
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,"Osteoarthritis, Knee",MESH:D020370,1,Iodoacetic Acid,0,
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
glycogen phosphorylase activity,GO:0008184,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
GPI anchor binding,GO:0034235,Osteoarthritis,MESH:D010003,0,,1,DPEP1
G protein activity,GO:0003925,Osteoarthritis,MESH:D010003,0,,1,RAN
G-protein alpha-subunit binding,GO:0001965,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
G protein-coupled peptide receptor activity,GO:0008528,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
G protein-coupled receptor activity,GO:0004930,Osteoarthritis,MESH:D010003,0,,3,ADGRG2|FRZB|P3H3
G protein-coupled receptor activity,GO:0004930,"Osteoarthritis, Hip",MESH:D015207,0,,2,CRHR1|SMO
G protein-coupled serotonin receptor activity,GO:0004993,Osteoarthritis,MESH:D010003,0,,1,ESD
G-quadruplex DNA binding,GO:0051880,Osteoarthritis,MESH:D010003,0,,1,NME2
growth factor activity,GO:0008083,Osteoarthritis,MESH:D010003,0,,5,BMP4|BMP6|FGF18|GDF5|TGFB1
growth factor activity,GO:0008083,"Osteoarthritis, Hip",MESH:D015207,0,,1,IL11
growth factor activity,GO:0008083,"Osteoarthritis, Knee",MESH:D020370,0,,1,GDF5
growth factor activity,GO:0008083,"Osteoarthritis, Spine",MESH:D055013,0,,1,IL6
growth factor binding,GO:0019838,Osteoarthritis,MESH:D010003,0,,1,SDCBP
growth factor binding,GO:0019838,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
growth factor binding,GO:0019838,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
GTPase activating protein binding,GO:0032794,Osteoarthritis,MESH:D010003,0,,1,PLCD1
GTPase activator activity,GO:0005096,Osteoarthritis,MESH:D010003,0,,1,SEC23A
GTPase activity,GO:0003924,Osteoarthritis,MESH:D010003,0,,4,DDX3X|EEF2|OPA1|RAN
GTPase binding,GO:0051020,Osteoarthritis,MESH:D010003,0,,1,ENO1
GTPase-dependent fusogenic activity,GO:0140523,Osteoarthritis,MESH:D010003,0,,1,OPA1
GTP binding,GO:0005525,Osteoarthritis,MESH:D010003,0,,5,AK4|EEF2|OPA1|RAN|TGM2
H3K27me3 modified histone binding,GO:0061628,Osteoarthritis,MESH:D010003,1,Acetaminophen,0,
heat shock protein binding,GO:0031072,Osteoarthritis,MESH:D010003,0,,1,ENO1
heat shock protein binding,GO:0031072,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
helicase activity,GO:0004386,Osteoarthritis,MESH:D010003,0,,1,DDX3X
heme binding,GO:0020037,Osteoarthritis,MESH:D010003,0,,2,PSMB1|PTGS2
heparan sulfate binding,GO:1904399,"Osteoarthritis, Hip",MESH:D015207,0,,1,COL11A1
heparan sulfate proteoglycan binding,GO:0043395,Osteoarthritis,MESH:D010003,0,,2,ATP1A3|COMP
heparan sulfate proteoglycan binding,GO:0043395,"Osteoarthritis, Hip",MESH:D015207,0,,1,COMP
heparin binding,GO:0008201,Osteoarthritis,MESH:D010003,0,,4,ASPN|BMP4|COMP|CXCL6
heparin binding,GO:0008201,"Osteoarthritis, Hip",MESH:D015207,0,,2,COL11A1|COMP
heparin binding,GO:0008201,"Osteoarthritis, Spine",MESH:D055013,0,,1,CXCL8
heterocyclic compound binding,GO:1901363,Osteoarthritis,MESH:D010003,0,,1,NME2
hexokinase activity,GO:0004396,Osteoarthritis,MESH:D010003,2,Dietary Fats|Indomethacin,0,
hexokinase activity,GO:0004396,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
hexose transmembrane transporter activity,GO:0015149,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
high mobility group box 1 binding,GO:0070379,Osteoarthritis,MESH:D010003,0,,1,AGER
high voltage-gated calcium channel activity,GO:0008331,Osteoarthritis,MESH:D010003,1,Ethanol,0,
histamine receptor activity,GO:0004969,"Osteoarthritis, Hip",MESH:D015207,0,,1,DIABLO
histone acetyltransferase activity,GO:0004402,Osteoarthritis,MESH:D010003,2,astaxanthine|Curcumin,1,TRAP1
histone binding,GO:0042393,Osteoarthritis,MESH:D010003,0,,1,AGER
histone binding,GO:0042393,"Osteoarthritis, Knee",MESH:D020370,0,,1,SBNO1
histone deacetylase activity,GO:0004407,Osteoarthritis,MESH:D010003,3,astaxanthine|Curcumin|Dietary Fats,0,
histone deacetylase activity,GO:0004407,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone deacetylase binding,GO:0042826,Osteoarthritis,MESH:D010003,0,,1,RUNX2
histone deacetylase binding,GO:0042826,"Osteoarthritis, Hip",MESH:D015207,0,,2,HDAC9|RUNX2
histone-dependent DNA binding,GO:0099077,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
histone dopaminyltransferase activity,GO:0120297,Osteoarthritis,MESH:D010003,0,,1,TGM2
histone H2S140 phosphatase activity,GO:0140791,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
histone H2Y142 phosphatase activity,GO:0140793,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
histone H3K14 deacetylase activity,GO:0031078,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone H3K4 deacetylase activity,GO:1990162,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone H3K9 deacetylase activity,GO:0032129,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone H3K9 demethylase activity,GO:0032454,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
histone H4K12 deacetylase activity,GO:0140937,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone H4K16 deacetylase activity,GO:0034739,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
histone serotonyltransferase activity,GO:0120295,Osteoarthritis,MESH:D010003,0,,1,TGM2
HMG box domain binding,GO:0071837,Osteoarthritis,MESH:D010003,0,,1,POU3F3
hormone activity,GO:0005179,Osteoarthritis,MESH:D010003,0,,1,CALCA
Hsp90 protein binding,GO:0051879,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
hyaluronic acid binding,GO:0005540,"Osteoarthritis, Hip",MESH:D015207,0,,1,ITIH1
hyaluronic acid binding,GO:0005540,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
hydrolase activity,GO:0016787,Osteoarthritis,MESH:D010003,0,,11,ACTB|CTSD|CTSK|DDX3X|DPEP1|ESD|GLS|HIBCH|OPA1|PLCD1|RAN
hydrolase activity,GO:0016787,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",GO:0016810,Osteoarthritis,MESH:D010003,0,,1,DPYSL2
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",GO:0016812,Osteoarthritis,MESH:D010003,0,,1,DPYSL2
"hydrolase activity, acting on ester bonds",GO:0016788,Osteoarthritis,MESH:D010003,0,,1,ESD
identical protein binding,GO:0042802,Osteoarthritis,MESH:D010003,0,,32,ACTB|AGER|BMP4|CALCA|COL1A2|COL2A1|DPEP1|DPYSL2|ENO1|ESD|EZR|FTL|GAPDH|GDF5|GLS|MVP|NME2|PDCD6IP|PPARG|S100A4|SDCBP|SLC2A1|SMAD3|SOD2|TGFB1|TGM2|TRAP1|TRPV4|TXNRD1|VDAC2|VIM|YWHAQ
identical protein binding,GO:0042802,"Osteoarthritis, Hip",MESH:D015207,0,,2,MAPT|SMAD3
identical protein binding,GO:0042802,"Osteoarthritis, Knee",MESH:D020370,0,,1,GDF5
identical protein binding,GO:0042802,"Osteoarthritis, Spine",MESH:D055013,0,,3,IL6|SKP2|TNF
identical protein binding,GO:0042802,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
IgE binding,GO:0019863,Osteoarthritis,MESH:D010003,0,,1,LGALS3
IkappaB kinase activity,GO:0008384,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
IkappaB kinase activity,GO:0008384,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
importin-alpha family protein binding,GO:0061676,Osteoarthritis,MESH:D010003,0,,1,RAN
indanol dehydrogenase activity,GO:0047718,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
"indoleamine 2,3-dioxygenase activity",GO:0033754,Osteoarthritis,MESH:D010003,1,Lipopolysaccharides,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
"inositol 1,3,4,5 tetrakisphosphate binding",GO:0043533,"Osteoarthritis, Hip",MESH:D015207,0,,1,ASTN2
"inositol 1,4,5 trisphosphate binding",GO:0070679,Osteoarthritis,MESH:D010003,0,,1,PLCD1
integrin binding,GO:0005178,Osteoarthritis,MESH:D010003,0,,3,COMP|EDIL3|IL1B
integrin binding,GO:0005178,"Osteoarthritis, Hip",MESH:D015207,0,,2,COMP|TNC
interleukin-11 receptor binding,GO:0005142,"Osteoarthritis, Hip",MESH:D015207,0,,1,IL11
interleukin-1 receptor binding,GO:0005149,Osteoarthritis,MESH:D010003,0,,1,IL1B
interleukin-5 receptor binding,GO:0005137,Osteoarthritis,MESH:D010003,0,,1,SDCBP
interleukin-6 receptor binding,GO:0005138,"Osteoarthritis, Spine",MESH:D055013,0,,1,IL6
interleukin-8 receptor binding,GO:0005153,"Osteoarthritis, Spine",MESH:D055013,0,,1,CXCL8
intermediate filament binding,GO:0019215,Osteoarthritis,MESH:D010003,0,,1,NME2
ionotropic glutamate receptor binding,GO:0035255,Osteoarthritis,MESH:D010003,0,,1,SDCBP
iron ion binding,GO:0005506,Osteoarthritis,MESH:D010003,0,,3,FTL|P3H3|PLOD2
iron-responsive element binding,GO:0030350,Osteoarthritis,MESH:D010003,0,,1,ACO1
iron-sulfur cluster binding,GO:0051536,Osteoarthritis,MESH:D010003,0,,2,ACO1|NDUFV1
I-SMAD binding,GO:0070411,Osteoarthritis,MESH:D010003,0,,1,SMAD3
I-SMAD binding,GO:0070411,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
isocitrate dehydrogenase (NAD+) activity,GO:0004449,Osteoarthritis,MESH:D010003,0,,1,IDH3A
isocitrate dehydrogenase (NADP+) activity,GO:0004450,Osteoarthritis,MESH:D010003,0,,1,IDH2
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,Osteoarthritis,MESH:D010003,1,Iron,0,
JUN kinase activity,GO:0004705,Osteoarthritis,MESH:D010003,1,Lipopolysaccharides,0,
JUN kinase activity,GO:0004705,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
JUN kinase kinase kinase kinase activity,GO:0042656,Osteoarthritis,MESH:D010003,0,,1,MSN
keratin filament binding,GO:1990254,Osteoarthritis,MESH:D010003,0,,1,VIM
ketosteroid monooxygenase activity,GO:0047086,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
kinase activity,GO:0016301,Osteoarthritis,MESH:D010003,0,,2,AK4|NME2
kinase activity,GO:0016301,"Osteoarthritis, Spine",MESH:D055013,0,,1,SKP2
kinase binding,GO:0019900,Osteoarthritis,MESH:D010003,0,,3,OPA1|SLC2A1|VIM
kinesin binding,GO:0019894,Osteoarthritis,MESH:D010003,0,,1,ACTB
lactate dehydrogenase activity,GO:0004457,Osteoarthritis,MESH:D010003,11,Acetaminophen|Caffeine|Celecoxib|Curcumin|Decitabine|Dietary Fats|Ethanol|Lipopolysaccharides|Nicotine|Resveratrol|Tramadol,0,
lactate dehydrogenase activity,GO:0004457,"Osteoarthritis, Knee",MESH:D020370,3,Lipopolysaccharides|Resveratrol|Tramadol,0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,Osteoarthritis,MESH:D010003,1,Acetaminophen,0,
laminin binding,GO:0043236,Osteoarthritis,MESH:D010003,0,,1,LGALS3
laminin receptor activity,GO:0005055,Osteoarthritis,MESH:D010003,0,,1,AGER
L-ascorbic acid binding,GO:0031418,Osteoarthritis,MESH:D010003,0,,2,P3H3|PLOD2
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,Osteoarthritis,MESH:D010003,11,Acetaminophen|Caffeine|Curcumin|Diclofenac|Dietary Fats|Ethanol|Iron|Lipopolysaccharides|Nicotine|Resveratrol|Tramadol,0,
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,"Osteoarthritis, Knee",MESH:D020370,3,Lipopolysaccharides|Resveratrol|Tramadol,0,
LBD domain binding,GO:0050693,Osteoarthritis,MESH:D010003,0,,1,PPARG
ligase activity,GO:0016874,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
lipase activity,GO:0016298,Osteoarthritis,MESH:D010003,1,Ethanol,0,
lipid binding,GO:0008289,Osteoarthritis,MESH:D010003,0,,2,OPA1|TRPV4
lipoprotein particle binding,GO:0071813,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
lithocholic acid binding,GO:1902121,Osteoarthritis,MESH:D010003,0,,1,AKR1C2
lncRNA binding,GO:0106222,Osteoarthritis,MESH:D010003,0,,1,EEF2
long-chain-3-hydroxyacyl-CoA dehydrogenase activity,GO:0016509,Osteoarthritis,MESH:D010003,0,,1,HADHA
long-chain fatty acid-CoA ligase activity,GO:0004467,Osteoarthritis,MESH:D010003,1,Diclofenac,0,
long-chain fatty acid transporter activity,GO:0005324,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
low-density lipoprotein particle receptor binding,GO:0050750,Osteoarthritis,MESH:D010003,0,,1,CLU
lyase activity,GO:0016829,Osteoarthritis,MESH:D010003,0,,3,ACO1|ENO1|HADHA
lysine-acetylated histone binding,GO:0070577,Osteoarthritis,MESH:D010003,3,Acetaminophen|Ethanol|Nicotine,0,
magnesium ion binding,GO:0000287,Osteoarthritis,MESH:D010003,0,,6,ENO1|IDH2|IDH3A|OPA1|RAN|TRAP1
malate dehydrogenase activity,GO:0016615,Osteoarthritis,MESH:D010003,2,Acetaminophen|Curcumin,0,
malic enzyme activity,GO:0004470,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
manganese ion binding,GO:0030145,Osteoarthritis,MESH:D010003,0,,1,SOD2
MAP kinase kinase kinase kinase activity,GO:0008349,Osteoarthritis,MESH:D010003,0,,1,MSN
MAP kinase serine/threonine phosphatase activity,GO:1990439,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
MAP kinase tyrosine phosphatase activity,GO:0033550,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017017,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
membrane scission GTPase motor activity,GO:1990606,Osteoarthritis,MESH:D010003,0,,1,OPA1
mercury ion binding,GO:0045340,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
metal ion binding,GO:0046872,Osteoarthritis,MESH:D010003,0,,27,ACO1|ATP1A3|COL1A2|COL2A1|DPEP1|ENO1|IDH2|IDH3A|NDUFS8|NDUFV1|NME2|OPA1|P3H3|PDHA1|PLCD1|PLOD2|PLS3|PPARG|PTGS2|RAN|RCN3|SEC23A|SMAD3|SOD2|TGM2|TRAP1|TRPV4
metal ion binding,GO:0046872,"Osteoarthritis, Hip",MESH:D015207,0,,4,COL11A1|HDAC9|LMX1B|SMAD3
metal ion binding,GO:0046872,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
metal ion binding,GO:0046872,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
metallodipeptidase activity,GO:0070573,Osteoarthritis,MESH:D010003,0,,1,DPEP1
metalloexopeptidase activity,GO:0008235,Osteoarthritis,MESH:D010003,0,,1,DPEP1
metallopeptidase activity,GO:0008237,Osteoarthritis,MESH:D010003,0,,1,DPEP1
methylated histone binding,GO:0035064,Osteoarthritis,MESH:D010003,1,Acetaminophen,0,
methyltransferase activity,GO:0008168,"Osteoarthritis, Spine",MESH:D055013,0,,1,SKP2
methylumbelliferyl-acetate deacetylase activity,GO:0047374,Osteoarthritis,MESH:D010003,0,,1,ESD
MHC class II protein binding,GO:0042289,Osteoarthritis,MESH:D010003,0,,1,COL2A1
MHC class II protein binding,GO:0042289,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
microfibril binding,GO:0050436,Osteoarthritis,MESH:D010003,0,,1,LTBP3
microfibril binding,GO:0050436,"Osteoarthritis, Hip",MESH:D015207,0,,1,LTBP3
microfibril binding,GO:0050436,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
microfilament motor activity,GO:0000146,Osteoarthritis,MESH:D010003,0,,1,MYH13
microtubule binding,GO:0008017,Osteoarthritis,MESH:D010003,0,,5,EZR|GAPDH|LTBP3|OPA1|TRPV4
microtubule binding,GO:0008017,"Osteoarthritis, Hip",MESH:D015207,0,,2,LTBP3|MAPT
microtubule lateral binding,GO:0099609,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
minor groove of adenine-thymine-rich DNA binding,GO:0003680,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
misfolded protein binding,GO:0051787,Osteoarthritis,MESH:D010003,0,,1,CLU
mitogen-activated protein kinase binding,GO:0051019,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
modified amino acid binding,GO:0072341,Osteoarthritis,MESH:D010003,0,,1,DPEP1
molecular adaptor activity,GO:0060090,Osteoarthritis,MESH:D010003,0,,2,AGER|VIM
molecular adaptor activity,GO:0060090,"Osteoarthritis, Knee",MESH:D020370,0,,2,LTBP1|WWP2
molecular condensate scaffold activity,GO:0140693,Osteoarthritis,MESH:D010003,0,,1,LGALS3
molecular_function,GO:0003674,Osteoarthritis,MESH:D010003,0,,3,PDCD6IP|SCRN1|SGCG
molecular_function,GO:0003674,"Osteoarthritis, Hip",MESH:D015207,0,,1,FILIP1
monoatomic cation channel activity,GO:0005261,Osteoarthritis,MESH:D010003,1,Lipopolysaccharides,1,TRPV4
monoatomic cation channel activity,GO:0005261,"Osteoarthritis, Knee",MESH:D020370,2,Adenosine Triphosphate|Lipopolysaccharides,0,
monoatomic ion channel activity,GO:0005216,Osteoarthritis,MESH:D010003,0,,1,TRPV4
monooxygenase activity,GO:0004497,Osteoarthritis,MESH:D010003,0,,1,YWHAQ
monosaccharide binding,GO:0048029,Osteoarthritis,MESH:D010003,0,,1,LGALS3
mRNA 3'-UTR binding,GO:0003730,"Osteoarthritis, Knee",MESH:D020370,0,,1,MIR219A1
mRNA 5'-UTR binding,GO:0048027,Osteoarthritis,MESH:D010003,0,,2,ACO1|DDX3X
mRNA base-pairing translational repressor activity,GO:1903231,"Osteoarthritis, Knee",MESH:D020370,0,,1,MIR219A1
mRNA base-pairing translational repressor activity,GO:1903231,"Osteoarthritis, Spine",MESH:D055013,0,,1,MIR337
mRNA binding,GO:0003729,Osteoarthritis,MESH:D010003,0,,2,CLU|DDX3X
mRNA regulatory element binding translation repressor activity,GO:0000900,Osteoarthritis,MESH:D010003,0,,1,ACO1
myosin binding,GO:0017022,Osteoarthritis,MESH:D010003,0,,1,TRIM2
myosin phosphatase activity,GO:0017018,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
NAD binding,GO:0051287,Osteoarthritis,MESH:D010003,0,,5,GAPDH|HADHA|IDH2|IDH3A|NDUFV1
NAD+ binding,GO:0070403,Osteoarthritis,MESH:D010003,0,,1,HADHA
NADH dehydrogenase activity,GO:0003954,Osteoarthritis,MESH:D010003,0,,1,NDUFS8
NADH dehydrogenase (ubiquinone) activity,GO:0008137,Osteoarthritis,MESH:D010003,7,Acetaminophen|Curcumin|Dietary Fats|Ethanol|Lipopolysaccharides|Lithium Chloride|Resveratrol,2,NDUFS8|NDUFV1
NADH dehydrogenase (ubiquinone) activity,GO:0008137,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
NADP binding,GO:0050661,Osteoarthritis,MESH:D010003,0,,1,GAPDH
NADP+ binding,GO:0070401,Osteoarthritis,MESH:D010003,0,,1,AKR1C2
NADPH binding,GO:0070402,Osteoarthritis,MESH:D010003,0,,1,AKR1C2
NAD(P)H oxidase H2O2-forming activity,GO:0016174,Osteoarthritis,MESH:D010003,5,Celecoxib|Lipopolysaccharides|Nicotine|Resveratrol|rofecoxib,1,TXNRD1
NAD(P)H oxidase H2O2-forming activity,GO:0016174,"Osteoarthritis, Knee",MESH:D020370,4,argan oil|Lipopolysaccharides|Resveratrol|rofecoxib,0,
NADPH peroxidase activity,GO:0050137,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
neurexin family protein binding,GO:0042043,Osteoarthritis,MESH:D010003,0,,1,SDCBP
neuropeptide hormone activity,GO:0005184,Osteoarthritis,MESH:D010003,0,,1,CALCA
neurotransmitter receptor activity,GO:0030594,Osteoarthritis,MESH:D010003,0,,1,ESD
NF-kappaB binding,GO:0051059,Osteoarthritis,MESH:D010003,2,Ethanol|Lipopolysaccharides,0,
NF-kappaB binding,GO:0051059,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
nitric-oxide synthase activity,GO:0004517,Osteoarthritis,MESH:D010003,3,Caffeine|Dietary Fats|Resveratrol,0,
nitric-oxide synthase activity,GO:0004517,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
nitric-oxide synthase binding,GO:0050998,Osteoarthritis,MESH:D010003,0,,1,ACTB
non-membrane spanning protein tyrosine phosphatase activity,GO:0004726,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
nuclear estrogen receptor binding,GO:0030331,Osteoarthritis,MESH:D010003,0,,1,PPARG
nuclear export signal receptor activity,GO:0005049,Osteoarthritis,MESH:D010003,0,,1,RAN
nuclear glucocorticoid receptor binding,GO:0035259,Osteoarthritis,MESH:D010003,0,,1,SMAD3
nuclear glucocorticoid receptor binding,GO:0035259,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
nuclear mineralocorticoid receptor binding,GO:0031962,Osteoarthritis,MESH:D010003,0,,1,SMAD3
nuclear mineralocorticoid receptor binding,GO:0031962,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
nuclear receptor activity,GO:0004879,Osteoarthritis,MESH:D010003,0,,1,PPARG
nuclear receptor binding,GO:0016922,Osteoarthritis,MESH:D010003,0,,1,SMAD3
nuclear receptor binding,GO:0016922,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
nuclear retinoid X receptor binding,GO:0046965,Osteoarthritis,MESH:D010003,0,,1,PPARG
nucleic acid binding,GO:0003676,Osteoarthritis,MESH:D010003,0,,6,AK4|CLIC1|DAPP1|DDX3X|OPA1|PPARG
nucleobase-containing compound kinase activity,GO:0019205,Osteoarthritis,MESH:D010003,0,,1,AK4
nucleoside diphosphate kinase activity,GO:0004550,Osteoarthritis,MESH:D010003,0,,2,AK4|NME2
nucleoside monophosphate kinase activity,GO:0050145,Osteoarthritis,MESH:D010003,0,,1,AK4
nucleoside triphosphate adenylate kinase activity,GO:0046899,Osteoarthritis,MESH:D010003,0,,1,AK4
nucleosomal DNA binding,GO:0031492,Osteoarthritis,MESH:D010003,0,,1,ACTB
nucleotide binding,GO:0000166,Osteoarthritis,MESH:D010003,0,,6,AK4|GAPDH|OPA1|RAN|TRAP1|TXNRD1
oligosaccharide binding,GO:0070492,Osteoarthritis,MESH:D010003,0,,1,LGALS3
osmosensor activity,GO:0005034,Osteoarthritis,MESH:D010003,0,,1,TRPV4
oxidoreductase activity,GO:0016491,Osteoarthritis,MESH:D010003,0,,17,AKR1C1|AKR1C2|ALDH1A2|CLIC1|CLIC4|ETFA|GAPDH|GSTK1|HADHA|IDH2|IDH3A|P3H3|PDHA1|PLOD2|SDHA|SOD2|TXNRD1
"oxidoreductase activity, acting on NAD(P)H",GO:0016651,Osteoarthritis,MESH:D010003,1,Curcumin,1,NDUFS8
"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",GO:0016655,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",GO:0016705,Osteoarthritis,MESH:D010003,0,,2,P3H3|PLOD2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",GO:0016701,Osteoarthritis,MESH:D010003,0,,1,PTGS2
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",GO:0016702,Osteoarthritis,MESH:D010003,0,,1,PTGS2
"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor",GO:0016624,Osteoarthritis,MESH:D010003,0,,1,PDHA1
"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",GO:0016620,Osteoarthritis,MESH:D010003,0,,2,ALDH1A2|GAPDH
"oxidoreductase activity, acting on the CH-CH group of donors",GO:0016627,Osteoarthritis,MESH:D010003,0,,1,SDHA
"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0016616,Osteoarthritis,MESH:D010003,0,,3,HADHA|IDH2|IDH3A
"oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor",GO:0016901,Osteoarthritis,MESH:D010003,0,,1,SDHA
oxygen binding,GO:0019825,Osteoarthritis,MESH:D010003,2,Curcumin|Resveratrol,1,SOD2
oxygen binding,GO:0019825,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
oxysterol binding,GO:0008142,Osteoarthritis,MESH:D010003,0,,1,VDAC2
oxysterol binding,GO:0008142,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
p53 binding,GO:0002039,Osteoarthritis,MESH:D010003,0,,1,EEF2
parathyroid hormone receptor activity,GO:0004991,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
patched binding,GO:0005113,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
peptidase activator activity involved in apoptotic process,GO:0016505,Osteoarthritis,MESH:D010003,1,Ethanol,0,
peptidase activity,GO:0008233,Osteoarthritis,MESH:D010003,1,Diclofenac,4,CTSD|CTSK|DPEP1|TGM2
peptidase inhibitor activity,GO:0030414,Osteoarthritis,MESH:D010003,0,,1,TFPI2
peptide antigen binding,GO:0042605,"Osteoarthritis, Hip",MESH:D015207,0,,1,HFE
peptide binding,GO:0042277,Osteoarthritis,MESH:D010003,0,,2,CTSD|PPARG
peptide binding,GO:0042277,"Osteoarthritis, Hip",MESH:D015207,0,,1,CRHR1
peptide histaminyltransferase activity,GO:0120299,Osteoarthritis,MESH:D010003,0,,1,TGM2
peptide noradrenalinyltransferase activity,GO:0120298,Osteoarthritis,MESH:D010003,0,,1,TGM2
peptidyl-cysteine S-nitrosylase activity,GO:0035605,Osteoarthritis,MESH:D010003,0,,1,GAPDH
peroxidase activity,GO:0004601,Osteoarthritis,MESH:D010003,1,Curcumin,1,PTGS2
phosphatase activity,GO:0016791,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
phosphatase binding,GO:0019902,Osteoarthritis,MESH:D010003,0,,1,SMAD3
phosphatase binding,GO:0019902,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
phosphatidic acid binding,GO:0070300,Osteoarthritis,MESH:D010003,0,,2,OPA1|PLCD1
phosphatidic acid binding,GO:0070300,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
phosphatidylcholine binding,GO:0031210,Osteoarthritis,MESH:D010003,0,,1,VDAC2
"phosphatidylinositol-3,4,5-trisphosphate binding",GO:0005547,Osteoarthritis,MESH:D010003,0,,1,DAPP1
"phosphatidylinositol-3,4-bisphosphate binding",GO:0043325,Osteoarthritis,MESH:D010003,0,,1,DAPP1
"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",GO:0004439,Osteoarthritis,MESH:D010003,0,,1,PLCD1
"phosphatidylinositol-4,5-bisphosphate binding",GO:0005546,Osteoarthritis,MESH:D010003,0,,2,PLCD1|SDCBP
phosphatidylinositol-4-phosphate binding,GO:0070273,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
phosphatidylinositol binding,GO:0035091,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
phosphatidylinositol bisphosphate binding,GO:1902936,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
phosphatidylinositol phospholipase C activity,GO:0004435,Osteoarthritis,MESH:D010003,0,,1,PLCD1
phosphatidylserine binding,GO:0001786,Osteoarthritis,MESH:D010003,0,,1,PLCD1
phosphatidylserine floppase activity,GO:0090556,Osteoarthritis,MESH:D010003,1,Reactive Oxygen Species,0,
phosphofructokinase activity,GO:0008443,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
phospholipase A2 activity,GO:0004623,Osteoarthritis,MESH:D010003,2,Diclofenac|Indomethacin,0,
phospholipase A2 activity,GO:0004623,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
phospholipase binding,GO:0043274,Osteoarthritis,MESH:D010003,0,,1,TGM2
phospholipid binding,GO:0005543,Osteoarthritis,MESH:D010003,0,,2,DAPP1|PLCD1
phospholipid scramblase activity,GO:0017128,Osteoarthritis,MESH:D010003,0,,1,VDAC2
phosphoprotein phosphatase activity,GO:0004721,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
phosphopyruvate hydratase activity,GO:0004634,Osteoarthritis,MESH:D010003,0,,1,ENO1
phosphorelay sensor kinase activity,GO:0000155,Osteoarthritis,MESH:D010003,0,,1,NME2
"phosphotransferase activity, for other substituted phosphate groups",GO:0016780,Osteoarthritis,MESH:D010003,0,,1,MVP
"phosphotransferase activity, phosphate group as acceptor",GO:0016776,Osteoarthritis,MESH:D010003,0,,1,AK4
platelet-derived growth factor binding,GO:0048407,Osteoarthritis,MESH:D010003,0,,2,COL1A2|COL2A1
platelet-derived growth factor binding,GO:0048407,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
poly(A) binding,GO:0008143,Osteoarthritis,MESH:D010003,0,,1,DDX3X
pore-forming activity,GO:0140911,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
porin activity,GO:0015288,Osteoarthritis,MESH:D010003,0,,1,VDAC2
pre-miRNA binding,GO:0070883,Osteoarthritis,MESH:D010003,0,,1,RAN
primary miRNA binding,GO:0070878,Osteoarthritis,MESH:D010003,0,,1,DDX3X
procollagen-lysine 5-dioxygenase activity,GO:0008475,Osteoarthritis,MESH:D010003,0,,1,PLOD2
procollagen-proline 3-dioxygenase activity,GO:0019797,Osteoarthritis,MESH:D010003,0,,1,P3H3
promoter-specific chromatin binding,GO:1990841,Osteoarthritis,MESH:D010003,0,,2,PPARG|SMAD3
promoter-specific chromatin binding,GO:1990841,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
prostaglandin-endoperoxide synthase activity,GO:0004666,Osteoarthritis,MESH:D010003,1,Diclofenac,1,PTGS2
prostaglandin receptor activity,GO:0004955,Osteoarthritis,MESH:D010003,0,,1,PPARG
protease binding,GO:0002020,Osteoarthritis,MESH:D010003,0,,2,COL1A2|COMP
protease binding,GO:0002020,"Osteoarthritis, Hip",MESH:D015207,0,,1,COMP
protease binding,GO:0002020,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
protein antigen binding,GO:1990405,Osteoarthritis,MESH:D010003,0,,1,PPP2R1A
proteinase activated receptor binding,GO:0031871,Osteoarthritis,MESH:D010003,0,,1,PDCD6IP
protein binding,GO:0005515,Osteoarthritis,MESH:D010003,0,,85,ACAA2|ACO1|ACTB|AGER|AK4|AKR1C1|ASPN|ATP1A3|ATP6V1B2|BMP4|BMP6|CALCA|CHI3L1|CLIC1|CLIC4|CLU|COL1A2|COL2A1|COL6A2|COMP|CTSD|CTSK|CXCL2|CXCL6|DAPP1|DDX3X|DPEP1|DPYSL2|EEF2|ENO1|ESD|ETFA|EZR|FRZB|FTL|GAPDH|GDF5|GLS|GSTK1|HADHA|IDH3A|IL1B|IMMT|ISOC2|LGALS3|LTBP3|MATN3|MSN|MVP|MYH13|NDUFS8|NDUFV1|NME2|OPA1|P3H3|PDCD6IP|PDHA1|PLCD1|POU3F3|PPARG|PPP2R1A|PSMB1|PTGS2|RAN|RCN3|RUNX2|S100A4|SCRN1|SDCBP|SDHA|SEC23A|SGCG|SLC2A1|SMAD3|SOD2|TGFB1|TGM2|TNFSF15|TRAP1|TRIM2|TRPV4|TXNRD1|VDAC2|VIM|YWHAQ
protein binding,GO:0005515,"Osteoarthritis, Hip",MESH:D015207,0,,17,ASTN2|CHADL|COL11A1|COMP|CRHR1|DIABLO|HDAC9|HFE|IL11|ITIH1|LMX1B|LTBP3|MAPT|RUNX2|SMAD3|SMO|TNC
protein binding,GO:0005515,"Osteoarthritis, Knee",MESH:D020370,0,,4,GDF5|LTBP1|SBNO1|WWP2
protein binding,GO:0005515,"Osteoarthritis, Spine",MESH:D055013,0,,5,CXCL8|DUSP1|IL6|SKP2|TNF
protein binding,GO:0005515,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
protein binding,GO:0005515,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
protein carrier chaperone,GO:0140597,Osteoarthritis,MESH:D010003,0,,1,CLU
protein-containing complex binding,GO:0044877,Osteoarthritis,MESH:D010003,0,,12,AGER|CALCA|CLIC4|CLU|ENO1|EZR|HADHA|OPA1|RAN|S100A4|SDCBP|TGFB1
protein-containing complex binding,GO:0044877,"Osteoarthritis, Hip",MESH:D015207,0,,2,CRHR1|MAPT
protein dimerization activity,GO:0046983,Osteoarthritis,MESH:D010003,0,,3,COMP|PDCD6IP|RUNX2
protein dimerization activity,GO:0046983,"Osteoarthritis, Hip",MESH:D015207,0,,2,COMP|RUNX2
protein dimerization activity,GO:0046983,"Osteoarthritis, Knee",MESH:D020370,0,,1,SBNO1
protein domain specific binding,GO:0019904,Osteoarthritis,MESH:D010003,0,,7,EZR|IL1B|RAN|RUNX2|TGM2|VIM|YWHAQ
protein domain specific binding,GO:0019904,"Osteoarthritis, Hip",MESH:D015207,0,,1,RUNX2
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,Osteoarthritis,MESH:D010003,0,,1,TGM2
protein-glutamine glutaminase activity,GO:0050568,Osteoarthritis,MESH:D010003,0,,1,TGM2
protein heterodimerization activity,GO:0046982,Osteoarthritis,MESH:D010003,0,,5,BMP6|CLU|PPP2R1A|RAN|SDCBP
protein homodimerization activity,GO:0042803,Osteoarthritis,MESH:D010003,0,,6,COL2A1|ENO1|PDCD6IP|POU3F3|PTGS2|SMAD3
protein homodimerization activity,GO:0042803,"Osteoarthritis, Hip",MESH:D015207,0,,2,SMAD3|SMO
protein homodimerization activity,GO:0042803,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
protein kinase A binding,GO:0051018,Osteoarthritis,MESH:D010003,0,,1,EZR
protein kinase A catalytic subunit binding,GO:0034236,Osteoarthritis,MESH:D010003,0,,1,EZR
protein kinase A catalytic subunit binding,GO:0034236,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
protein kinase activity,GO:0004672,Osteoarthritis,MESH:D010003,0,,2,EEF2|MSN
protein kinase A regulatory subunit binding,GO:0034237,Osteoarthritis,MESH:D010003,0,,1,EZR
protein kinase binding,GO:0019901,Osteoarthritis,MESH:D010003,0,,8,ACTB|DPYSL2|EEF2|MSN|MVP|SMAD3|TRAP1|TRPV4
protein kinase binding,GO:0019901,"Osteoarthritis, Hip",MESH:D015207,0,,3,MAPT|SMAD3|SMO
protein kinase C binding,GO:0005080,Osteoarthritis,MESH:D010003,0,,1,TRPV4
protein kinase C binding,GO:0005080,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
protein lysine deacetylase activity,GO:0033558,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
protein-macromolecule adaptor activity,GO:0030674,Osteoarthritis,MESH:D010003,0,,2,COL1A2|MSN
protein-macromolecule adaptor activity,GO:0030674,"Osteoarthritis, Hip",MESH:D015207,0,,2,COL11A1|MAPT
protein phosphatase 2A binding,GO:0051721,Osteoarthritis,MESH:D010003,0,,1,VIM
protein phosphatase 2A binding,GO:0051721,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
protein phosphatase binding,GO:0019903,Osteoarthritis,MESH:D010003,0,,3,LGALS3|MVP|PPARG
protein phosphatase inhibitor activity,GO:0004864,Osteoarthritis,MESH:D010003,0,,1,LGALS3
protein phosphatase regulator activity,GO:0019888,Osteoarthritis,MESH:D010003,0,,1,PPP2R1A
protein sequestering activity,GO:0140311,Osteoarthritis,MESH:D010003,0,,1,SDCBP
protein sequestering activity,GO:0140311,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
protein serine/threonine kinase activator activity,GO:0043539,Osteoarthritis,MESH:D010003,0,,3,BMP4|DDX3X|TGFB1
protein serine/threonine kinase activity,GO:0004674,Osteoarthritis,MESH:D010003,0,,1,NME2
protein serine/threonine phosphatase activity,GO:0004722,Osteoarthritis,MESH:D010003,0,,1,PPP2R1A
protein serine/threonine phosphatase activity,GO:0004722,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
protein tyrosine kinase binding,GO:1990782,Osteoarthritis,MESH:D010003,0,,1,VIM
protein tyrosine phosphatase activity,GO:0004725,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
"protein tyrosine phosphatase activity, metal-dependent",GO:0030946,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
protein tyrosine/serine/threonine phosphatase activity,GO:0008138,Osteoarthritis,MESH:D010003,0,,1,ATP6V1B2
protein tyrosine/serine/threonine phosphatase activity,GO:0008138,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
protein tyrosine/threonine phosphatase activity,GO:0008330,"Osteoarthritis, Spine",MESH:D055013,0,,1,DUSP1
proteoglycan binding,GO:0043394,Osteoarthritis,MESH:D010003,0,,3,COL2A1|COMP|CTSK
proteoglycan binding,GO:0043394,"Osteoarthritis, Hip",MESH:D015207,0,,1,COMP
proteoglycan binding,GO:0043394,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
proton transmembrane transporter activity,GO:0015078,Osteoarthritis,MESH:D010003,0,,1,ATP6V1B2
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,Osteoarthritis,MESH:D010003,2,Curcumin|Resveratrol,1,ATP6V1B2
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
P-type calcium transporter activity,GO:0005388,Osteoarthritis,MESH:D010003,2,Curcumin|Lipopolysaccharides,0,
P-type calcium transporter activity,GO:0005388,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
P-type potassium transmembrane transporter activity,GO:0008556,Osteoarthritis,MESH:D010003,0,,1,ATP1A3
P-type sodium:potassium-exchanging transporter activity,GO:0005391,Osteoarthritis,MESH:D010003,7,Curcumin|Dietary Fats|Dinoprostone|Ethanol|Indomethacin|Lipopolysaccharides|Resveratrol,1,ATP1A3
P-type sodium:potassium-exchanging transporter activity,GO:0005391,"Osteoarthritis, Hip",MESH:D015207,1,Indomethacin,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,"Osteoarthritis, Knee",MESH:D020370,2,Lipopolysaccharides|Resveratrol,0,
P-type sodium:potassium-exchanging transporter activity involved in regulation of cardiac muscle cell membrane potential,GO:0086037,Osteoarthritis,MESH:D010003,0,,1,ATP1A3
pyruvate dehydrogenase (acetyl-transferring) activity,GO:0004739,Osteoarthritis,MESH:D010003,1,Dietary Fats,1,PDHA1
pyruvate dehydrogenase activity,GO:0004738,Osteoarthritis,MESH:D010003,1,Dietary Fats,1,PDHA1
pyruvate dehydrogenase (NAD+) activity,GO:0034604,Osteoarthritis,MESH:D010003,0,,1,PDHA1
RAGE receptor binding,GO:0050786,Osteoarthritis,MESH:D010003,0,,1,S100A4
receptor ligand activity,GO:0048018,Osteoarthritis,MESH:D010003,0,,2,CLU|IL1B
receptor ligand activity,GO:0048018,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
receptor tyrosine kinase binding,GO:0030971,Osteoarthritis,MESH:D010003,0,,1,DAPP1
retinal binding,GO:0016918,Osteoarthritis,MESH:D010003,0,,1,ALDH1A2
retinal dehydrogenase activity,GO:0001758,Osteoarthritis,MESH:D010003,0,,1,ALDH1A2
ribonucleoside triphosphate phosphatase activity,GO:0017111,Osteoarthritis,MESH:D010003,0,,1,DDX3X
ribosomal small subunit binding,GO:0043024,Osteoarthritis,MESH:D010003,0,,1,DDX3X
ribosome binding,GO:0043022,Osteoarthritis,MESH:D010003,0,,2,CLU|EEF2
RISC complex binding,GO:1905172,Osteoarthritis,MESH:D010003,0,,1,RAN
RNA binding,GO:0003723,Osteoarthritis,MESH:D010003,0,,7,ACO1|AGER|DDX3X|EEF2|ENO1|TRAP1|VIM
RNA binding,GO:0003723,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
RNA helicase activity,GO:0003724,Osteoarthritis,MESH:D010003,0,,1,DDX3X
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,Osteoarthritis,MESH:D010003,0,,4,POU3F3|PPARG|RUNX2|SMAD3
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,Osteoarthritis,MESH:D010003,0,,1,PPARG
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,Osteoarthritis,MESH:D010003,0,,1,SMAD3
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,"Osteoarthritis, Hip",MESH:D015207,0,,2,HDAC9|SMAD3
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,Osteoarthritis,MESH:D010003,0,,3,ENO1|PPARG|SMAD3
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,"Osteoarthritis, Hip",MESH:D015207,0,,2,LMX1B|SMAD3
RNA stem-loop binding,GO:0035613,Osteoarthritis,MESH:D010003,0,,1,DDX3X
RNA strand annealing activity,GO:0033592,Osteoarthritis,MESH:D010003,0,,1,DDX3X
R-SMAD binding,GO:0070412,Osteoarthritis,MESH:D010003,0,,2,PPARG|SMAD3
R-SMAD binding,GO:0070412,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
S100 protein binding,GO:0044548,Osteoarthritis,MESH:D010003,0,,2,AGER|EZR
scaffold protein binding,GO:0097110,Osteoarthritis,MESH:D010003,0,,1,VIM
scavenger receptor activity,GO:0005044,Osteoarthritis,MESH:D010003,0,,1,AGER
selenate reductase activity,GO:0033797,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
semaphorin receptor activity,GO:0017154,Osteoarthritis,MESH:D010003,0,,1,TXNRD1
sequence-specific DNA binding,GO:0043565,Osteoarthritis,MESH:D010003,0,,3,POU3F3|PPARG|SMAD3
sequence-specific DNA binding,GO:0043565,"Osteoarthritis, Hip",MESH:D015207,0,,2,MAPT|SMAD3
sequence-specific double-stranded DNA binding,GO:1990837,Osteoarthritis,MESH:D010003,0,,1,RUNX2
sequence-specific double-stranded DNA binding,GO:1990837,"Osteoarthritis, Hip",MESH:D015207,0,,2,LMX1B|RUNX2
serine-type endopeptidase activity,GO:0004252,Osteoarthritis,MESH:D010003,0,,1,CTSK
serine-type endopeptidase activity,GO:0004252,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMO
serine-type endopeptidase inhibitor activity,GO:0004867,Osteoarthritis,MESH:D010003,0,,2,COL2A1|TFPI2
serine-type endopeptidase inhibitor activity,GO:0004867,"Osteoarthritis, Hip",MESH:D015207,0,,2,COL11A1|ITIH1
serine-type endopeptidase inhibitor activity,GO:0004867,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
S-formylglutathione hydrolase activity,GO:0018738,Osteoarthritis,MESH:D010003,0,,1,ESD
SH2 domain binding,GO:0042169,Osteoarthritis,MESH:D010003,0,,1,TRPV4
SH3 domain binding,GO:0017124,Osteoarthritis,MESH:D010003,0,,1,PDCD6IP
SH3 domain binding,GO:0017124,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
signaling adaptor activity,GO:0035591,Osteoarthritis,MESH:D010003,0,,2,DAPP1|DDX3X
signaling receptor activity,GO:0038023,Osteoarthritis,MESH:D010003,0,,2,AGER|EDIL3
signaling receptor activity,GO:0038023,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
signaling receptor binding,GO:0005102,Osteoarthritis,MESH:D010003,0,,5,CALCA|CLU|GDF5|MSN|TNFSF15
signaling receptor binding,GO:0005102,"Osteoarthritis, Hip",MESH:D015207,0,,1,HFE
signaling receptor binding,GO:0005102,"Osteoarthritis, Knee",MESH:D020370,0,,2,GDF5|LTBP1
signaling receptor binding,GO:0005102,"Osteoarthritis, Spine",MESH:D055013,0,,1,IL6
signaling receptor complex adaptor activity,GO:0030159,Osteoarthritis,MESH:D010003,0,,1,P3H3
signaling receptor inhibitor activity,GO:0030547,Osteoarthritis,MESH:D010003,0,,1,LGALS3
single-stranded DNA binding,GO:0003697,"Osteoarthritis, Hip",MESH:D015207,0,,1,MAPT
SMAD binding,GO:0046332,Osteoarthritis,MESH:D010003,0,,1,COL1A2
sodium channel activity,GO:0005272,Osteoarthritis,MESH:D010003,1,Resveratrol,0,
sodium channel activity,GO:0005272,"Osteoarthritis, Knee",MESH:D020370,1,Resveratrol,0,
starch synthase activity,GO:0009011,Osteoarthritis,MESH:D010003,2,Dietary Fats|Nicotine,0,
STAT family protein binding,GO:0097677,Osteoarthritis,MESH:D010003,0,,1,PPARG
steroid binding,GO:0005496,Osteoarthritis,MESH:D010003,0,,1,AKR1C2
steroid binding,GO:0005496,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
steroid dehydrogenase activity,GO:0016229,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0033764,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
steroid hormone binding,GO:1990239,Osteoarthritis,MESH:D010003,0,,1,ATP1A3
sterol response element binding,GO:0032810,Osteoarthritis,MESH:D010003,0,,1,SMAD3
sterol response element binding,GO:0032810,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
"stretch-activated, monoatomic cation-selective, calcium channel activity",GO:0015275,Osteoarthritis,MESH:D010003,0,,1,TRPV4
structural constituent of cytoskeleton,GO:0005200,Osteoarthritis,MESH:D010003,0,,3,ACTB|MSN|VIM
structural constituent of eye lens,GO:0005212,Osteoarthritis,MESH:D010003,0,,1,VIM
structural constituent of postsynaptic actin cytoskeleton,GO:0098973,Osteoarthritis,MESH:D010003,0,,1,ACTB
structural constituent of presynaptic actin cytoskeleton,GO:0098699,Osteoarthritis,MESH:D010003,0,,1,PLS3
structural molecule activity,GO:0005198,Osteoarthritis,MESH:D010003,0,,2,EZR|VIM
succinate dehydrogenase activity,GO:0000104,Osteoarthritis,MESH:D010003,4,Celecoxib|Curcumin|Dietary Fats|Lipopolysaccharides,1,SDHA
succinate dehydrogenase activity,GO:0000104,"Osteoarthritis, Knee",MESH:D020370,1,Lipopolysaccharides,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,Osteoarthritis,MESH:D010003,6,Acetaminophen|Aspirin|Curcumin|Dietary Fats|Ethanol|Lithium Chloride,1,SDHA
superoxide dismutase activity,GO:0004784,Osteoarthritis,MESH:D010003,23,Acetaminophen|Aspartame|Aspirin|astaxanthine|Capsaicin|Celecoxib|Curcumin|diacerein|Diclofenac|Dietary Fats|Ethanol|ferrostatin-1|fisetin|Ibuprofen|Indomethacin|Iron|Lipopolysaccharides|Lithium Chloride|Meloxicam|morroniside|Nicotine|oxymatrine|Resveratrol,1,SOD2
superoxide dismutase activity,GO:0004784,"Osteoarthritis, Hip",MESH:D015207,2,Ibuprofen|Indomethacin,1,COL11A1
superoxide dismutase activity,GO:0004784,"Osteoarthritis, Knee",MESH:D020370,3,argan oil|Lipopolysaccharides|Resveratrol,0,
superoxide-generating NADPH oxidase activity,GO:0106292,Osteoarthritis,MESH:D010003,1,Curcumin,0,
superoxide-generating NADPH oxidase activity,GO:0106292,"Osteoarthritis, Knee",MESH:D020370,1,argan oil,0,
syndecan binding,GO:0045545,Osteoarthritis,MESH:D010003,0,,1,SDCBP
syndecan binding,GO:0045545,"Osteoarthritis, Hip",MESH:D015207,0,,1,TNC
Tat protein binding,GO:0030957,Osteoarthritis,MESH:D010003,0,,1,ACTB
tau protein binding,GO:0048156,Osteoarthritis,MESH:D010003,0,,2,ACTB|CLU
testosterone 17-beta-dehydrogenase (NADP+) activity,GO:0047045,Osteoarthritis,MESH:D010003,0,,1,AKR1C1
thioredoxin-disulfide reductase activity,GO:0004791,Osteoarthritis,MESH:D010003,2,Curcumin|Iron,1,TXNRD1
"trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity",GO:0047115,Osteoarthritis,MESH:D010003,0,,2,AKR1C1|AKR1C2
transaminase activity,GO:0008483,Osteoarthritis,MESH:D010003,0,,1,TGM2
transcription cis-regulatory region binding,GO:0000976,Osteoarthritis,MESH:D010003,0,,3,PPARG|RUNX2|SMAD3
transcription cis-regulatory region binding,GO:0000976,"Osteoarthritis, Hip",MESH:D015207,0,,2,RUNX2|SMAD3
transcription cis-regulatory region binding,GO:0000976,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
transcription coactivator activity,GO:0003713,Osteoarthritis,MESH:D010003,0,,3,NME2|TRAP1|TXNRD1
transcription coactivator activity,GO:0003713,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
transcription coactivator binding,GO:0001223,Osteoarthritis,MESH:D010003,0,,2,PPARG|SMAD3
transcription coactivator binding,GO:0001223,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
transcription coregulator binding,GO:0001221,Osteoarthritis,MESH:D010003,0,,1,PPARG
transcription corepressor activity,GO:0003714,Osteoarthritis,MESH:D010003,0,,1,ENO1
transcription corepressor activity,GO:0003714,"Osteoarthritis, Hip",MESH:D015207,0,,1,HDAC9
transcription corepressor binding,GO:0001222,Osteoarthritis,MESH:D010003,0,,2,ENO1|SMAD3
transcription corepressor binding,GO:0001222,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
transcription factor binding,GO:0008134,Osteoarthritis,MESH:D010003,0,,1,DDX3X
transcription factor binding,GO:0008134,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
transferase activity,GO:0016740,Osteoarthritis,MESH:D010003,0,,5,ACAA2|AK4|GAPDH|GSTK1|TRIM2
transferase activity,GO:0016740,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
transferase activity,GO:0016740,"Osteoarthritis, Spine",MESH:D055013,0,,1,SKP2
transferrin receptor binding,GO:1990459,"Osteoarthritis, Hip",MESH:D015207,0,,1,HFE
transforming growth factor beta binding,GO:0050431,Osteoarthritis,MESH:D010003,0,,1,LTBP3
transforming growth factor beta binding,GO:0050431,"Osteoarthritis, Hip",MESH:D015207,0,,1,LTBP3
transforming growth factor beta binding,GO:0050431,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
transforming growth factor beta receptor activity,GO:0005024,"Osteoarthritis, Knee",MESH:D020370,0,,1,LTBP1
transforming growth factor beta receptor binding,GO:0005160,Osteoarthritis,MESH:D010003,0,,2,SMAD3|TGFB1
transforming growth factor beta receptor binding,GO:0005160,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
transition metal ion binding,GO:0046914,Osteoarthritis,MESH:D010003,0,,1,S100A4
translation elongation factor activity,GO:0003746,Osteoarthritis,MESH:D010003,0,,1,EEF2
translation initiation factor binding,GO:0031369,Osteoarthritis,MESH:D010003,0,,1,DDX3X
translation repressor activity,GO:0030371,Osteoarthritis,MESH:D010003,0,,1,TRIM2
transmembrane signaling receptor activity,GO:0004888,Osteoarthritis,MESH:D010003,0,,1,AGER
transmembrane signaling receptor activity,GO:0004888,"Osteoarthritis, Hip",MESH:D015207,0,,3,CHADL|CRHR1|SMO
transmembrane signaling receptor activity,GO:0004888,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS,OMIM:165800,0,,1,ACAN
transmembrane transporter activity,GO:0022857,Osteoarthritis,MESH:D010003,0,,2,CLU|SLC2A1
transmembrane transporter binding,GO:0044325,Osteoarthritis,MESH:D010003,0,,1,YWHAQ
triglyceride lipase activity,GO:0004806,Osteoarthritis,MESH:D010003,1,Dietary Fats,0,
tRNA-intron endonuclease activity,GO:0000213,Osteoarthritis,MESH:D010003,0,,1,PPARG
tumor necrosis factor receptor binding,GO:0005164,Osteoarthritis,MESH:D010003,0,,2,TNFSF15|TRAP1
tumor necrosis factor receptor binding,GO:0005164,"Osteoarthritis, Spine",MESH:D055013,0,,1,TNF
type 1 fibroblast growth factor receptor binding,GO:0005105,Osteoarthritis,MESH:D010003,0,,1,FGF18
type 2 fibroblast growth factor receptor binding,GO:0005111,Osteoarthritis,MESH:D010003,0,,1,FGF18
type III transforming growth factor beta receptor binding,GO:0034714,Osteoarthritis,MESH:D010003,0,,1,TGFB1
type II transforming growth factor beta receptor binding,GO:0005114,Osteoarthritis,MESH:D010003,0,,1,TGFB1
type I transforming growth factor beta receptor binding,GO:0034713,Osteoarthritis,MESH:D010003,0,,1,TGFB1
ubiquinol-cytochrome-c reductase activity,GO:0008121,Osteoarthritis,MESH:D010003,2,Acetaminophen|Curcumin,0,
ubiquitin binding,GO:0043130,Osteoarthritis,MESH:D010003,0,,1,SMAD3
ubiquitin binding,GO:0043130,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
ubiquitin ligase-substrate adaptor activity,GO:1990756,"Osteoarthritis, Spine",MESH:D055013,0,,1,SKP2
ubiquitin protein ligase activity,GO:0061630,Osteoarthritis,MESH:D010003,0,,2,DAPP1|TRIM2
ubiquitin protein ligase activity,GO:0061630,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
ubiquitin protein ligase binding,GO:0031625,Osteoarthritis,MESH:D010003,0,,2,CLU|SMAD3
ubiquitin protein ligase binding,GO:0031625,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
ubiquitin-protein transferase activity,GO:0004842,Osteoarthritis,MESH:D010003,0,,1,TRIM2
ubiquitin-protein transferase activity,GO:0004842,"Osteoarthritis, Knee",MESH:D020370,0,,1,WWP2
unfolded protein binding,GO:0051082,Osteoarthritis,MESH:D010003,0,,2,CLU|TRAP1
vitamin D binding,GO:0005499,Osteoarthritis,MESH:D010003,0,,1,COMP
vitamin D binding,GO:0005499,"Osteoarthritis, Hip",MESH:D015207,0,,1,COMP
voltage-gated channel activity,GO:0022832,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
voltage-gated chloride channel activity,GO:0005247,Osteoarthritis,MESH:D010003,0,,1,CLIC1
voltage-gated chloride channel activity,GO:0005247,"Osteoarthritis, Knee",MESH:D020370,1,Adenosine Triphosphate,0,
voltage-gated monoatomic anion channel activity,GO:0008308,Osteoarthritis,MESH:D010003,0,,1,VDAC2
voltage-gated monoatomic ion channel activity,GO:0005244,Osteoarthritis,MESH:D010003,0,,1,VDAC2
Wnt-protein binding,GO:0017147,Osteoarthritis,MESH:D010003,0,,1,FRZB
Wnt receptor activity,GO:0042813,Osteoarthritis,MESH:D010003,0,,1,FRZB
WW domain binding,GO:0050699,Osteoarthritis,MESH:D010003,0,,1,PPARG
xanthine oxidase activity,GO:0004855,Osteoarthritis,MESH:D010003,1,Diclofenac,0,
xenobiotic transmembrane transporter activity,GO:0042910,Osteoarthritis,MESH:D010003,0,,1,SLC2A1
zinc ion binding,GO:0008270,Osteoarthritis,MESH:D010003,0,,9,AK4|CLIC1|CLU|DPEP1|OPA1|PPARG|SEC23A|SMAD3|TRIM2
zinc ion binding,GO:0008270,"Osteoarthritis, Hip",MESH:D015207,0,,1,SMAD3
